Lebenthal Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Lebenthal Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$9.35M	Buy	171,950 +2,706	+2%	+$148K	1.16%	13
2016 Q4	$9.89M	Buy	169,244 +1,085	+0.6%	+$59.3K	1.27%	11
2016 Q3	$9.07M	Buy	168,159 +6,477	+4%	+$416K	1.18%	14
2016 Q2	$11.9M	Buy	161,682 +105,312	+187%	+$7.44M	1.54%	7
2016 Q1	$3.6M	Buy	+56,370	New	+$3.55M	1.46%	34

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lebenthal Asset Management's BMY Position: Q1 2017 in Review

Lebenthal Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2017, buying an estimated $148K and bringing the position to 171,950 shares worth $9.35M. The position accounts for 1.16% of the portfolio, ranked #13.

Lebenthal Asset Management first reported a position in BMY in Q1 2016 and has held it in 5 quarters since. The position peaked at $11.9M in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Lebenthal Asset Management held 171,950 shares of Bristol-Myers Squibb worth $9.35M as of Q1 2017.
Lebenthal Asset Management bought 2,706 Bristol-Myers Squibb shares in Q1 2017, an estimated $148K.
Bristol-Myers Squibb made up 1.16% of Lebenthal Asset Management's portfolio in Q1 2017, its #13 holding.
Lebenthal Asset Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 5 quarters since.
Lebenthal Asset Management's Bristol-Myers Squibb position peaked at $11.9M in Q2 2016.
1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.